Anti-parasitic drug kills COVID-19 virus in lab grown cells: Study


PTI, Apr 4, 2020, 6:28 PM IST

Melbourne: Researchers have found that an anti-parasitic drug already available around the world can kill the novel coronavirus grown in cell cultures within 48 hours, an advance that may lead to the development and trial of a new clinical therapy for COVID-19.

According to the study, published in the journal Antiviral Research, the drug, Ivermectin, stopped the virus, SARS-CoV-2, from growing in cell culture within 48 hours.

“We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it,” said study co-author Kylie Wagstaff from Monash University in Australia.

The scientists said Ivermectin is an approved antiparasitic drug that has also been shown to be effective in vitro against a broad range of viruses including HIV, Dengue, Influenza and Zika virus.

However, Wagstaff cautioned that the tests conducted in the study were in vitro and that trials needed to be carried out in people.

“Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective – that’s the next step,” Wagstaff said.

“In times when we’re having a global pandemic and there isn’t an approved treatment, if we had a compound that was already available around the world then that might help people sooner,” she said.

Although the mechanism by which Ivermectin works on the virus is not known, the scientists said it is likely, based on its action in other viruses, that it works to stop the virus ‘dampening down’ the host cells’ ability to clear it.

“As the virologist who was part of the team who were first to isolate and share SARS-COV2 outside of China in January 2020, I am excited about the prospect of Ivermectin being used as a potential drug against COVID-19,” said Leon Caly, study co-author from the Royal Melbourne Hospital in Australia.

The scientists further cautioned that the use of Ivermectin to combat COVID-19 would depend on the results of future pre-clinical testing and ultimately clinical trials.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

CM Bommai boasts about Karnataka’s number one position in FDI inflow, as he leaves for Davos

Albanese elected Australia’s leader in complex poll result

Umran Malik selected for T20Is vs SA; Hardik in shortest format, Pujara in Test earn recalls

Bengaluru: Man sentenced to 7 years in jail for abetment to suicide

Shivakumar rejects differences with Siddaramaiah, says together recommended MLC candidates

Taliban enforcing face-cover order for female TV anchors

Amid Gyanvapi controversy, Hindus claim temple in Srirangapatna was converted into Jamia Masjid


Related Articles More

In Your Debt: How debt-related stress affects body and mind

Monkeypox: What is it and how can we prevent the spread?

Treating sleep apnoea can improve memory in people with cognitive decline

Why do we get teary when we’re tired or sick?

Psychedelics: how they act on the brain to relieve depression

MUST WATCH

High tech Bust stand Inaguration at Shirva

NEWS BULLETIN 21-05-2022

We will have 2 options

Chikkamagaluru DC statement Namaz at Dattapeeta video goes viral

Kalasa Crime : CCTV Footage found


Latest Additions

CM Bommai boasts about Karnataka’s number one position in FDI inflow, as he leaves for Davos

Ajay Devgn-like car stunt lands Noida man in jail

Albanese elected Australia’s leader in complex poll result

‘Half Ticket’: Musical comedy paying homage to Kishore Kumar to stage in capital on May 28

Umran Malik selected for T20Is vs SA; Hardik in shortest format, Pujara in Test earn recalls

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.